These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3414142)

  • 21. Combination chemotherapy for multiple myeloma with melphalan, prednisone, cyclophosphamide, vincristine, and carmustine (BCNU) (M-2 protocol).
    Tirelli U; Crivellari D; Carbone A; Veronesi A; Galligioni E; Trovò MG; Tumolo S; Grigoletto E
    Cancer Treat Rep; 1982 Nov; 66(11):1971-3. PubMed ID: 6897205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of multiple myeloma in stages I and II. Comparative study of an M-2 protocol and melphalan-prednisone].
    Montalbán C; Zapatero A; Blanco L; Sevilla F; García Laraña J; Odriozola J
    Sangre (Barc); 1984; 29(6):993-9. PubMed ID: 6549486
    [No Abstract]   [Full Text] [Related]  

  • 23. [Combination chemotherapy with vincristine, melphalan, CCNA, cyclophosphamide, prednisone in myeloma].
    Le Loët X; Monconduit M; Menard JF; Deshayes P; Grobois B; Tanguy A; Prevost E; Piguet H
    Rev Rhum Mal Osteoartic; 1984 May; 51(5):263-7. PubMed ID: 6740189
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acquired immunodeficiency syndrome-related lymphoma: simultaneous treatment with combined cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy and highly active antiretroviral therapy is safe and improves survival--results of the German Multicenter Trial.
    Weiss R; Mitrou P; Arasteh K; Schuermann D; Hentrich M; Duehrsen U; Sudeck H; Schmidt-Wolf IG; Anagnostopoulos I; Huhn D
    Cancer; 2006 Apr; 106(7):1560-8. PubMed ID: 16502436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Four versus six courses of a dose-escalated cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen plus etoposide (megaCHOEP) and autologous stem cell transplantation: early dose intensity is crucial in treating younger patients with poor prognosis aggressive lymphoma.
    Schmitz N; Kloess M; Reiser M; Berdel WE; Metzner B; Dorken B; Kneba M; Trumper L; Loeffler M; Pfreundschuh M; Glass B;
    Cancer; 2006 Jan; 106(1):136-45. PubMed ID: 16331635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined therapy in the treatment of primary mediastinal B-cell lymphoma: conventional versus escalated chemotherapy.
    Avilés A; García EL; Fernández R; Gonzalez JL; Neri N; Díaz-Maqueo JC
    Ann Hematol; 2002 Jul; 81(7):368-73. PubMed ID: 12185505
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-dose therapy and autologous blood stem-cell transplantation compared with conventional treatment in myeloma patients aged 55 to 65 years: long-term results of a randomized control trial from the Group Myelome-Autogreffe.
    Fermand JP; Katsahian S; Divine M; Leblond V; Dreyfus F; Macro M; Arnulf B; Royer B; Mariette X; Pertuiset E; Belanger C; Janvier M; Chevret S; Brouet JC; Ravaud P;
    J Clin Oncol; 2005 Dec; 23(36):9227-33. PubMed ID: 16275936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapy for multiple myeloma with alternating non-cross-resistant chemotherapy combinations: heterogeneity of tumor responsiveness.
    Morstyn G; Schechter GP; Ihde DC; Carney DN; Eddy JL; Cohen MH; Minna JD; Bunn PA
    Cancer Treat Rep; 1984 Dec; 68(12):1439-46. PubMed ID: 6391662
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical efficacy of combined treatment in a late-stage malignant tumor of the head and neck].
    Jin BL
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1987 May; 22(3):162-3. PubMed ID: 3478183
    [No Abstract]   [Full Text] [Related]  

  • 30. Long term remission of Sjögren's syndrome associated aggressive B cell non-Hodgkin's lymphomas following combined B cell depletion therapy and CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone).
    Voulgarelis M; Giannouli S; Tzioufas AG; Moutsopoulos HM
    Ann Rheum Dis; 2006 Aug; 65(8):1033-7. PubMed ID: 16322082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [High-dose chemotherapy with autologous peripheral blood stem cell transplantation for the treatment of multiple myeloma refractory to conventional chemotherapy].
    Shimokawa T; Kajiguchi T; Saito M; Kojima Y; Takeyama H
    Gan To Kagaku Ryoho; 2003 Feb; 30(2):251-4. PubMed ID: 12610874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Intensive treatment of T-cell-rich B lymphoma].
    Azaceta G; Palomera L; Varo MJ; Soria J
    Sangre (Barc); 1998 Feb; 43(1):94-5. PubMed ID: 9577190
    [No Abstract]   [Full Text] [Related]  

  • 33. [Solitary rhinosinusal plasmacytoma. A review of its diagnosis and treatment].
    Gallego de la Fuente MC; Medina Banegas A; de la Cierva F; Osete Albaladejo JM
    An Otorrinolaringol Ibero Am; 1990; 17(6):591-8. PubMed ID: 2077926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The therapeutic efficacy of VBCMP-M2 protocol in multiple myeloma.
    Colović MD; Janković GM; Nikolov VS; Suvajdzić ND; Miletić VD
    Haematologia (Budap); 1994; 26(2):91-6. PubMed ID: 7890267
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Interim results of the combination of M2 polychemotherapy with calcitonin and synthetic anabolic agents in the treatment of plasmacytoma].
    Fremiotti A; Castellani R; Barbatano L; Salerno L; Bartolini M
    Recenti Prog Med; 1979 Apr; 66(4):418-26. PubMed ID: 113855
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment of hyperviscosity syndrome in the patients with plasma cell dyscrasias.
    Kes P; Pecanić Z; Getaldić B; Ratković-Gusić I
    Acta Med Croatica; 1996; 50(4-5):173-7. PubMed ID: 9046114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rate of M-component changes and clinical course of 23 responsive myeloma patients.
    Riccardi A; Montecucco C; Merlini G; Cremonini N; Danova M; Ascari E
    Haematologica; 1984; 69(3):305-14. PubMed ID: 6432642
    [No Abstract]   [Full Text] [Related]  

  • 38. [Results of the treatment of primary gastric lymphomas--chemotherapy after gastrectomy].
    Takagi T; Oguro M; Omori Y; Honda I; Fujita Y
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2601-4. PubMed ID: 6210056
    [No Abstract]   [Full Text] [Related]  

  • 39. Plasma cell leukemia--report on two cases.
    Singh VP; Sundar S; Kumar K; Shukla J; Dube B
    J Assoc Physicians India; 1994 Oct; 42(10):824-5. PubMed ID: 7876056
    [No Abstract]   [Full Text] [Related]  

  • 40. High dose chemotherapy followed by autologous haemopoietic stem cell transplant in multiple myeloma.
    Kumar L; Raju GM; Ganessan K; Shawgi S; Menon H; Wadhwa J; Sharma A; Singh R; Kochupillai V
    Natl Med J India; 2003; 16(1):16-21. PubMed ID: 12715951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.